epcoritamab
genmab,abbvie
['bet', 'dlbcl', 'cll', 'epcoritamab', ' ibru', 'fil,veral,12', 'epcore,nhl,1', '2019', 'nhl', 'epcore,nhl,i,(-ii)', 'epcore,nhl,2', 'lymsm', 'emergent ']
congress | #ash22 arnon p. kater, shared early results of the epcore cll-1 trial of epcortitamab, a bsab, in richter's syndrome. no pts dicontinued due to teaes. an orr of 60% and cr of 50% was observed.
#lymsm #medicalcongress #hematology 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm